This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tran, C. P. Articles by Reiter, R. E. Search for Related Content PubMed PubMed Citation Articles by Tran, C. P. Articles by Reiter, R. E.

---

Cancer Genes and Genomics

Prostate Stem Cell Antigen Is a Marker of Late Intermediate Prostate Epithelial Cells¹

¹ Department of Urology, Molecular Biology Institute (RER), Geffen School of Medicine at the University of California, Los Angeles, CA

Requests for reprints: Robert E. Reiter, 66-128 Center for the Health Sciences, 10833 Le Conte Avenue, Los Angeles, CA 90095. Phone: (310) 794-7224; Fax: (310) 206-5343. E-mail:rreiter{at}mednet.ucla.edu

Prostate stem cell antigen (PSCA, named for its strong sequence homology to the thymocyte marker stem cell antigen 2) is a cell surface antigen expressed in normal prostate and associated with human and murine prostate cancer. To begin to investigate a possible link between PSCA expression in normal prostate and prostate carcinogenesis, we characterized the phenotype and proliferative behavior of normal PSCA-expressing prostate epithelial cells (PrEC) in tissue culture. PSCA was expressed in a subset of prostate epithelial cells that coexpress basal and secretory cytokeratins. PSCA-positive cells were the direct progeny of PSCA-negative cells and were characterized by a more differentiated morphology and a slower proliferative rate than PSCA-negative cells. Although PSCA-positive cells continued to express basal cell markers such as CD44, they lost expression of the basal cell marker p63. In contrast, expression of prostate specific antigen and androgen receptor transcripts was detectable in PSCA-positive PrEC. These findings suggest that PSCA is a unique marker of an intermediate subpopulation of PrEC in transition from a basal to a terminally differentiated secretory phenotype and may be a useful marker for the study of normal and malignant prostate development.

This article has been cited by other articles:

				D. J. Vander Griend, W. L. Karthaus, S. Dalrymple, A. Meeker, A. M. DeMarzo, and J. T. Isaacs The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells Cancer Res., December 1, 2008; 68(23): 9703 - 9711. [Abstract] [Full Text] [PDF]

				R.U. Lukacs, D.A. Lawson, L. Xin, Y. Zong, I. Garraway, A.S. Goldstein, S. Memarzadeh, and O.N. Witte Epithelial Stem Cells of the Prostate and Their Role in Cancer Progression Cold Spring Harb Symp Quant Biol, November 6, 2008; (2008) sqb.2008.73.012v1. [Abstract] [PDF]

				J. V. Leyton, T. Olafsen, M. A. Sherman, K. B. Bauer, P. Aghajanian, R. E. Reiter, and A. M. Wu Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors Protein Eng. Des. Sel., October 28, 2008; (2008) gzn055v1. [Abstract] [Full Text] [PDF]

				M. Mimeault, P. P. Mehta, R. Hauke, and S. K. Batra Functions of Normal and Malignant Prostatic Stem/Progenitor Cells in Tissue Regeneration and Cancer Progression and Novel Targeting Therapies Endocr. Rev., April 1, 2008; 29(2): 234 - 252. [Abstract] [Full Text] [PDF]

				L. Xin, R. U. Lukacs, D. A. Lawson, D. Cheng, and O. N. Witte Self-Renewal and Multilineage Differentiation In Vitro from Murine Prostate Stem Cells Stem Cells, November 1, 2007; 25(11): 2760 - 2769. [Abstract] [Full Text] [PDF]

				J. Jiao, S. Wang, R. Qiao, I. Vivanco, P. A. Watson, C. L. Sawyers, and H. Wu Murine Cell Lines Derived from Pten Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer Development Cancer Res., July 1, 2007; 67(13): 6083 - 6091. [Abstract] [Full Text] [PDF]

				Z. Zhou, A. Flesken-Nikitin, and A. Yu. Nikitin Prostate Cancer Associated with p53 and Rb Deficiency Arises from the Stem/Progenitor Cell-Enriched Proximal Region of Prostatic Ducts Cancer Res., June 15, 2007; 67(12): 5683 - 5690. [Abstract] [Full Text] [PDF]

				P Singh, A Uzgare, I Litvinov, S R Denmeade, and J T Isaacs Combinatorial androgen receptor targeted therapy for prostate cancer. Endocr. Relat. Cancer, September 1, 2006; 13(3): 653 - 666. [Abstract] [Full Text] [PDF]

				I. V. Litvinov, D. J. Vander Griend, Y. Xu, L. Antony, S. L. Dalrymple, and J. T. Isaacs Low-Calcium Serum-Free Defined Medium Selects for Growth of Normal Prostatic Epithelial Stem Cells. Cancer Res., September 1, 2006; 66(17): 8598 - 8607. [Abstract] [Full Text] [PDF]

				Z. Zheng, C. Cai, J. Omwancha, S.-Y. Chen, T. Baslan, and L. Shemshedini SUMO-3 Enhances Androgen Receptor Transcriptional Activity through a Sumoylation-independent Mechanism in Prostate Cancer Cells J. Biol. Chem., February 17, 2006; 281(7): 4002 - 4012. [Abstract] [Full Text] [PDF]

				S. Wang, A. J. Garcia, M. Wu, D. A. Lawson, O. N. Witte, and H. Wu Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation PNAS, January 31, 2006; 103(5): 1480 - 1485. [Abstract] [Full Text] [PDF]

				P. A. Watson, K. Ellwood-Yen, J. C. King, J. Wongvipat, M. M. LeBeau, and C. L. Sawyers Context-Dependent Hormone-Refractory Progression Revealed through Characterization of a Novel Murine Prostate Cancer Cell Line Cancer Res., December 15, 2005; 65(24): 11565 - 11571. [Abstract] [Full Text] [PDF]

				A. T. Collins, P. A. Berry, C. Hyde, M. J. Stower, and N. J. Maitland Prospective Identification of Tumorigenic Prostate Cancer Stem Cells Cancer Res., December 1, 2005; 65(23): 10946 - 10951. [Abstract] [Full Text] [PDF]

				C. A. Sartorius, D. M.E. Harvell, T. Shen, and K. B. Horwitz Progestins Initiate a Luminal to Myoepithelial Switch in Estrogen-Dependent Human Breast Tumors without Altering Growth Cancer Res., November 1, 2005; 65(21): 9779 - 9788. [Abstract] [Full Text] [PDF]

				S. Dalrymple, L. Antony, Y. Xu, A. R. Uzgare, J. T. Arnold, J. Savaugeot, L. J. Sokoll, A. M. De Marzo, and J. T. Isaacs Role of Notch-1 and E-Cadherin in the Differential Response to Calcium in Culturing Normal versus Malignant Prostate Cells Cancer Res., October 15, 2005; 65(20): 9269 - 9279. [Abstract] [Full Text] [PDF]

				D M Peehl Primary cell cultures as models of prostate cancer development Endocr. Relat. Cancer, March 1, 2005; 12(1): 19 - 47. [Abstract] [Full Text] [PDF]

				D.A. LAWSON, L. XIN, R. LUKACS, Q. XU, D. CHENG, and O.N. WITTE Prostate Stem Cells and Prostate Cancer Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 187 - 196. [Abstract] [PDF]

				V. X. Fu, S. R. Schwarze, M. L. Kenowski, S. LeBlanc, J. Svaren, and D. F. Jarrard A Loss of Insulin-like Growth Factor-2 Imprinting Is Modulated by CCCTC-binding Factor Down-regulation at Senescence in Human Epithelial Cells J. Biol. Chem., December 10, 2004; 279(50): 52218 - 52226. [Abstract] [Full Text] [PDF]

				T. N. Alam, M. J. O'Hare, I. Laczko, A. Freeman, F. Al-Beidh, J. R. Masters, and D. L. Hudson Differential Expression of CD44 During Human Prostate Epithelial Cell Differentiation J. Histochem. Cytochem., August 1, 2004; 52(8): 1083 - 1090. [Abstract] [Full Text] [PDF]

				Z. Zhigang and S. Wenlv Prostate Stem Cell Antigen (PSCA) Expression in Human Prostate Cancer Tissues: Implications for Prostate Carcinogenesis and Progression of Prostate Cancer Jpn. J. Clin. Oncol., July 1, 2004; 34(7): 414 - 419. [Abstract] [Full Text] [PDF]

				X.-D. Wang, J. Shou, P. Wong, D. M. French, and W.-Q. Gao Notch1-expressing Cells Are Indispensable for Prostatic Branching Morphogenesis during Development and Re-growth Following Castration and Androgen Replacement J. Biol. Chem., June 4, 2004; 279(23): 24733 - 24744. [Abstract] [Full Text] [PDF]

				S. R. Schwarze, V. X. Fu, and D. F. Jarrard Cdc37 Enhances Proliferation and Is Necessary for Normal Human Prostate Epithelial Cell Survival Cancer Res., August 1, 2003; 63(15): 4614 - 4619. [Abstract] [Full Text] [PDF]